Open Access · CC BY-NC 4.0
Deep Response as a Novel Efficacy Endpoint in Hepatocellular Carcinoma
Liver Cancer · 30.07.2026 · 1-9
DOI: 10.1159/000553391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 30.07.2026. Verfasst von Masatoshi Kudo. Beteiligte Einrichtung: Editor-in-Chief, Liver Cancer, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Deep responseDepth responseHepatocellular carcinomaImmunotherapy
Autor:innen und Institutionen
- Editor-in-Chief, Liver Cancer, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
Zitieren
APA
Kudo, M. (2026). Deep Response as a Novel Efficacy Endpoint in Hepatocellular Carcinoma. Liver Cancer, 1-9. https://doi.org/10.1159/000553391
Vancouver
Kudo M. Deep Response as a Novel Efficacy Endpoint in Hepatocellular Carcinoma. Liver Cancer. 2026:1-9. doi:10.1159/000553391
BibTeX
@article{Kudo2026,
author = {Kudo, Masatoshi},
title = {Deep Response as a Novel Efficacy Endpoint in Hepatocellular Carcinoma},
journal = {Liver Cancer},
year = {2026},
pages = {1--9},
doi = {10.1159/000553391}
}
EUVIMED